30-May-2025 11:49 |
1.25p |
780,000 |
£9,750 |
Sell |
O |
30-May-2025 09:05 |
1.28p |
40,000 |
£510 |
Sell |
O |
30-May-2025 09:39 |
1.28p |
15,000 |
£191 |
Sell |
O |
30-May-2025 08:43 |
1.35p |
5,185 |
£70 |
Buy |
O |
30-May-2025 13:24 |
1.22p |
5,221 |
£64 |
Sell |
O |
30-May-2025 08:43 |
1.35p |
3,704 |
£50 |
Buy |
O |
30-May-2025 12:37 |
1.27p |
3,656 |
£46 |
Sell |
O |
30-May-2025 08:49 |
1.28p |
3,647 |
£46 |
Sell |
O |
30-May-2025 08:43 |
1.35p |
1,900 |
£26 |
Buy |
O |
30-May-2025 08:43 |
1.20p |
2,000 |
£24 |
Sell |
O |
30-May-2025 08:43 |
1.20p |
2,000 |
£24 |
Sell |
O |
30-May-2025 08:43 |
1.35p |
1,611 |
£22 |
Buy |
O |
30-May-2025 08:43 |
1.20p |
1,000 |
£12 |
Sell |
O |
30-May-2025 08:43 |
1.35p |
156 |
£2 |
Buy |
O |
16:11 |
30,000 @ 1.22p |
15:01 |
8,962 @ 1.27p |
13:24 |
5,221 @ 1.22p |
12:37 |
3,656 @ 1.27p |
11:49 |
780,000 @ 1.25p |
CFO |
Charles Osborne |
CEO |
Christopher von Jako |
Top of Page
You are here:
research